Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of June 24, 2024

In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more. Read the full coverage here:

Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis

Targeted psoriatic arthritis therapies demonstrate low risk for serious infection

VIDEO: Dermatologists, rheumatologists share care in psoriasis, psoriatic arthritis

Patients with arthritis at higher risk for poor nutrition regardless of function

FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older

References:

Bastard L, et al. RMD Open. 2024;doi:10.1136/rmdopen-2023-003865.

Bennett R, et al. Sci Rep. 2024;doi:10.1038/s41598-024-58370-7.

Husni ME. Update in the treatment of psoriatic arthritis. Presented at: Medical Dermatology Therapy Update III; May 29-31, 2024; Cleveland.

Press Release

Vassilakis KD, et al. Rheumatology. 2024;doi:10.1093/rheumatology/keae263.